Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Price of dulera inhaler?Darbepoetin injection cost?Can you name the ligand for pembrolizumab's target?Reyvow mechanism of action?Pirtobrutinib coupon?
See the DrugPatentWatch profile for Pirfenidone
Pirfenidone is used to treat idiopathic pulmonary fibrosis (IPF), a chronic, progressive lung disease that causes scarring of the lungs.
Based on its common approved use, pirfenidone is for IPF. It is not generally described as a treatment for unrelated conditions like asthma or infections; those would require different therapies aimed at different disease mechanisms.
Pirfenidone is an anti-fibrotic therapy. It helps slow the processes that lead to lung scarring (fibrosis), which is the core problem in IPF.
People starting pirfenidone often focus on tolerability and safety (for example, stomach upset or skin sensitivity), because those are common concerns with long-term anti-fibrotic treatment.
No sources were provided in your prompt. If you share the source text or a link you want me to use, I can answer with the required citations.
Other Questions About Pirfenidone :